051 Paulus-Alto

OHA completed a 30-day preliminary review of this transaction on May 13, 2025. The transaction was approved. The transaction closed on May 20, 2025. The one-year follow-up review commenced on May 20, 2026. 

To submit a public comment, tell us which transaction your comment is about and share your comment in one of these ways:

• Email hcmo.info@oha.oregon.gov 
  
• Leave a voicemail at 503-945-6161 
  
• Fill out the public comment form
  

OHA has published the following reports to date:

• Transaction Summary
• Report
• Order

• HCMO-1: Notice of Material Change Transaction
• Appendix to HCMO 1
• HCMO-1b: Business Entities Form
• Exhibit 6b: Project soprano Merger Agreement [Redacted]
• Exhibit 7: Letter of Intent [Redacted]
• Exhibit 7b: Project Soprano Financial Due Diligence Report [Redacted]
• Exhibit 7b: Project Soprano Tax Due Diligence Report [Redacted]
• Exhibit 10b: Paulus Governance Documents: Paulus Holdings Limited - Constitution [Redacted]
• Exhibit 10b: Paulus Governance Documents:Paulus Holdings Limited - Investment Agreement [Redacted]
• Exhibit 10b: Paulus Governance Documents: Postmeds, Inc. - Delaware COI
• Exhibit 10b: Paulus Governance Documents: Soprano Merger Sub II, LLC - Certificate of Formation
• Exhibit 10b: Paulus Governance Documents: Soprano Merger Sub II, LLC - LLC Agreement
• Exhibit 10b: Paulus Governance Documents: Soprano Merger Sub, Inc. - Bylaws
  
• Exhibit 10b: Paulus Governance Documents: Soprano Merger Sub, Inc. - Certificate of Formation
  
• Exhibit 10b: Paulus Governance Documents: Truepill, Inc. - Delaware A&R Certificate of Incorporation
• Exhibit 10b: Paulus Governance Documents: Truepill, Inc. - Revised Bylaws
• Exhibit 10b: Paulus Governance Documents: Truepill, Inc.- Bylaws
• Exhibit 10c: Paulus Structure Chart
• Exhibit 10e: Paulus Consolidated Financial Statement - FY2021 [Redacted]
• Exhibit 10e: Paulus Consolidated Financial Statement - FY2022 [Redacted]
• Exhibit 10e: Paulus Consolidated Financial Statement - FY2023 [Redacted]
• Exhibit 10e: Truepill Inc Consolidated Financial Reports_2022 [Redacted]
• Exhibit 10e: Truepill Inc Consolidated Financial Reports_2023 [Redacted]
• Exhibit 10e: Truepill Inc Consolidated Financial Reports_2024 [Redacted]
• Exhibit 11b: Alto Governance Documents: Alto Pharmacy Holdings, Inc. - A&R COI
• Exhibit 11b: Alto Governance Documents: Alto Pharmacy Investments, LLC - A&R LLCA
• Exhibit 11b: Alto Governance Documents: Alto Pharmacy Investments, LLC - Certificate of Formation
• Exhibit 11b: Alto Governance Documents: Alto Pharmacy LLC - A&R LLCA
• Exhibit 11b: Alto Governance Documents: Alto Pharmacy, Long Island, LLC - A&R Operating Agreement
• Exhibit 11b: Alto Governance Documents: Alto Pharmacy, Long Island, LLC - Articles of Organization
• Exhibit 11b: Alto Governance Documents: Candid Health Inc. - Bylaws
• Exhibit 11b: Alto Governance Documents: Candid Health Inc. - DE Certificate of Incorporation
• Exhibit 11b: Alto Governance Documents: Conception Pharmacy, LLC - A&R LLCA
  
• Exhibit 11b: Alto Governance Documents: Conception Pharmacy, LLC -Certificate of Formation
• Exhibit 11b: Alto Governance Documents: Alto-Pharmacy-Holdings, Inc. - A&R Bylaws
• Exhibit 11b: Alto Governance Documents: ScriptDash Inc. - Certificate of Conversion to Delaware LLC
• Exhibit 11b: Alto Governance Documents: ScriptDash Inc. - Certificate of Incorporation
• Exhibit 11b: Alto Governance Documents: ScriptDash Inc. - Restated COI (Series A - A-1)
  
• Exhibit 11c: Alto-Leadership-Organization-Chart [Redacted]
  
• Exhibit 11c: Alto-Organizational Structure Diagram
• Exhibit 11e: Alto Pharmacy Audit Report Consolidated Financial Statements FY23 FY22 [Redacted]
• Exhibit 11e: Alto Pharmacy Audit Report Consolidated Financial Statements FY22 FY21 [Redacted]
  
• Exhibit 13a: Project Soprano Transaction Structure Steps 
• Exhibit 16d: List of Competitors
  
• Redaction Log